Engineering the Immune Adaptor Protein STING as a Biologic
Xin Sun(Changsha Medical University), Jiahe Li(Shanxi Medical University), Shunsuke Kitajima(Japanese Foundation For Cancer Research), David A. Barbie(Dana-Farber Cancer Institute), Yun Ni(Northeastern University), Mengdi Yang(Nanjing Agricultural University), Yanpu He(Northeastern University), Tetsuo Tani(Keio University)
Cited by 1
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701